Why is Bharat Immunolog falling/rising?

As of 01-Aug, Bharat Immunological & Biological Corporation Ltd's stock price is currently at 22.09, reflecting a decrease of 0.29, or 1.3%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 3.03% during this period. It is trading below all its moving averages, indicating a bearish trend. Over the past year, the stock has generated a return of -29.96%, significantly underperforming the benchmark, which has only declined by 1.55%. The company's weak long-term fundamentals, highlighted by a lack of declared results in the last six months and poor growth metrics, further contribute to its negative performance. The recent financial results indicate a drastic decline in net sales and profit, which raises concerns about the company's ability to service its debt.
In the broader market context, the stock's short-term performance has been worse than the benchmark, with a 1-week decline of 3.33% compared to the Sensex's 1.06% drop. The pharmaceuticals and drugs sector, in which Bharat Immunolog operates, has also seen a decline of 3.27%, suggesting a challenging environment for the industry as a whole. Despite a notable increase in delivery volume, indicating rising investor participation, the overall sentiment remains negative due to the company's ongoing financial struggles and consistent underperformance against the benchmark over the last three years.